SCIAMPA M 12.5/500MG TAB 14`S

Metformin primarily works by suppressing hepatic glucose production. It inhibits gluconeogenesis and glycogenolysis in the liver, reducing the amount of glucose released into the bloodstream. Metformin also enhances insulin sensitivity in peripheral tissues, particularly in skeletal muscles, where it increases glucose uptake and utilization. Additionally, it may indirectly reduce appetite, leading to decreased food intake and calorie absorption. Empagliflozin, on the other hand, is an SGLT2 (sodium-glucose cotransporter-2) inhibitor. It acts by blocking the reabsorption of glucose in the kidneys, leading to increased glucose excretion in urine. This mechanism lowers blood glucose levels by reducing renal glucose reabsorption and promoting glucosuria, which helps improve glycemic control. Empagliflozin also promotes mild weight loss by eliminating excess glucose from the body.

The following are the uses of Metformin 500mg, Empagliflozin 12.5mg Tablet:

• Used for controlling blood sugar levels in patients with type 2 diabetes.
• Used to reduce the risk of cardiovascular events in diabetic patients.
• Used to aid in weight loss and improve insulin sensitivity.
• Used to lower the chances of diabetic kidney disease progression.
• Used to enhance glycemic control and promote better overall diabetes management.
• Used to support a healthy cardiovascular system in diabetic individuals.
• Used to regulate fluid balance and blood pressure.